Lipocine files $50M ATM equity facility with A.G.P./Alliance Global Partners

Lipocine Inc.

Filed prospectus supplement on Feb 26, 2026 for sale of up to $50M common stock via ATM.
Sales agreement originally dated April 26, 2024 with A.G.P./Alliance Global Partners.
Legal opinion on share validity from Dorsey & Whitney LLP included as Exhibit 5.1.
No specific use of proceeds disclosed in the 8-K.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.